B. Ahrén
Department of Medicine
Lund University
Malmö
Sweden
Name/email consistency: high
- 1,5-Anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice. Ahrén, B., Holst, J.J., Yu, S. Eur. J. Pharmacol. (2000)
- Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice. Ahrén, B., Holst, J.J., Mårtensson, H., Balkan, B. Eur. J. Pharmacol. (2000)
- Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat. Ahrén, B., Magrum, L.J., Havel, P.J., Greene, S.F., Phinney, S.D., Johnson, P.R., Stern, J.S. Obes. Res. (2000)
- Pharmacokinetics of human leptin in mice and rhesus monkeys. Ahrén, B., Baldwin, R.M., Havel, P.J. Int. J. Obes. Relat. Metab. Disord. (2000)
- The effects of PACAP on insulin secretion and glucose disposal are altered by adrenalectomy in mice. Ahrén, B., Filipsson, K. Ann. N. Y. Acad. Sci. (2000)
- Regulation of insulin secretion by nerves and neuropeptides. Ahrén, B. Ann. Acad. Med. Singap. (1999)
- Increased insulin secretion and normalization of glucose tolerance by cholinergic agonism in high fat-fed mice. Ahrén, B., Sauerberg, P., Thomsen, C. Am. J. Physiol. (1999)
- Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells). Ahrén, B., Havel, P.J. Am. J. Physiol. (1999)
- Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice. Ahrén, B., Pacini, G. Am. J. Physiol. (1999)
- Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. Ahrén, B., Pacini, G. J. Clin. Endocrinol. Metab. (1998)
- Pituitary adenylate cyclase activating polypeptide stimulates insulin secretion in a glucose-dependent manner in vivo. Ahrén, B., Filipsson, K. Ann. N. Y. Acad. Sci. (1998)
- Regulation of circulating leptin in humans. Ahrén, B., Larsson, H., Wilhelmsson, C., Näsman, B., Olsson, T. Endocrine (1997)